Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oncimmune Holdings PLC (GB:ONC)
LSE:ONC
RESEARCH TOOLSreports
Holding GB:ONC?
Track your performance easily
ONC Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range9.35p - 31.00p
Previous Close15.65p
Volume12.00K
Average Volume (3M)182.96K
Market Cap
£17.49M
Enterprise Value19.58M
Total Cash (Recent Filing)£3.21M
Total Debt (Recent Filing)£5.30M
Price to Earnings (P/E)1.8
Beta0.93
Next Earnings
Feb 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.10
Shares Outstanding80,142,147
10 Day Avg. Volume131,373
30 Day Avg. Volume182,956
Standard Deviation0.26
R-Squared0.00670
Alpha0.00889
Financial Highlights & Ratios
Price to Book (P/B)-782.50
Price to Sales (P/S)10.64
Price to Cash Flow (P/CF)-2.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Oncimmune Holdings News
PremiumCompany Announcements
Oncimmune Holdings Sees Change in Major Shareholder Voting Rights
PremiumCompany Announcements
Oncimmune Holdings’ Voting Rights Shift to IPF Management
PremiumCompany Announcements
Oncimmune Holdings Sees Shift in Voting Rights
PremiumCompany Announcements
Oncimmune Holdings Sees Change in Voting Rights Stake
PremiumCompany Announcements
Oncimmune Holdings Adjusts Shareholder Voting Rights
PremiumCompany Announcements
Oncimmune Holdings Executives Strengthen Stake Amid FundraisingPremiumCompany Announcements
Oncimmune Holdings Secures £2.3 Million Fundraising Boost
PremiumCompany Announcements
Oncimmune Holdings Raises £142,010 from Retail OfferOptions Prices
Currently, No data available
---
Ownership Overview
1.56% Insiders
<0.01% Mutual Funds
― Other Institutional Investors
98.44% Public Companies and
Individual Investors
ONC FAQ
What was Oncimmune Holdings PLC’s price range in the past 12 months?
Oncimmune Holdings PLC lowest share price was 9.35p and its highest was 31.00p in the past 12 months.
What is Oncimmune Holdings PLC’s market cap?
Currently, no data Available
When is Oncimmune Holdings PLC’s upcoming earnings report date?
Oncimmune Holdings PLC’s upcoming earnings report date is Feb 27, 2025 which is in 67 days.
How were Oncimmune Holdings PLC’s earnings last quarter?
Oncimmune Holdings PLC released its earnings results on May 21, 2024. The company reported 0.11p earnings per share for the quarter, beating the consensus estimate of N/A by 0.11p.
Is Oncimmune Holdings PLC overvalued?
According to Wall Street analysts Oncimmune Holdings PLC’s price is currently Overvalued.
Does Oncimmune Holdings PLC pay dividends?
Oncimmune Holdings PLC does not currently pay dividends.
What is Oncimmune Holdings PLC’s EPS estimate?
Oncimmune Holdings PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oncimmune Holdings PLC have?
Oncimmune Holdings PLC has 111,773,220 shares outstanding.
What happened to Oncimmune Holdings PLC’s price movement after its last earnings report?
Oncimmune Holdings PLC reported an EPS of 0.11p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.811%.
Which hedge fund is a major shareholder of Oncimmune Holdings PLC?
Currently, no hedge funds are holding shares in GB:ONC
---
Oncimmune Holdings Stock Smart Score
Company Description
Oncimmune Holdings PLC
Oncimmune Holdings PLC is engaged in diagnosing cancer. It is involved in the development, manufacture, and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer. The company's operating segment includes EarlyCDT and ImmunoINSIGHTS. It generates maximum revenue from the EarlyCDT segment.
---
Technical Analysis
---